Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
As tetanus vaccination rates decline, doctors worry about rising case numbers - 2Which Switch Game Do You Suggest? Share Your Decision
- 36 Popular Men's Aromas On the planet
- 4Evidence of lost baptismal rite stage uncovered in Byzantine era cathedral near Sea of Galilee
- 5Figure out how to Put resources into Lab Precious stones: A Novice's Aide
- Really focusing on Succulents: Tips and Procedures
- Commonsense Ways to work on Your Funds with a Restricted Pay
- Disney's latest short film 'Versa' tackles a difficult subject: Pregnancy loss. It's resonating with viewers.
- Artemis moon mission breaks record for distance from Earth
- Far-right leader Le Pen to attend Brigitte Bardot's funeral
- This Asian country is the next hot travel destination, and this is one of its best hotels
- Excelling at Cash The board: A Manual for Monetary Essentials
- Wizz CEO: We’re going to invest $1 b. in Israeli market
- Creative Style: 10 Architects Reclassifying the Business
